Diversity Action Plans Should Be Brief And Waiver Requests Filed Early, US FDA Says

 
• By Sue Sutter
Diverse hands
The FDA expects studies can be conducted with diversity action plans 'in most cases.' • Source: Shutterstock

More from Diversity & Inclusion

More from Clinical Trials